ReShape Lifesciences (RSLS)
NASDAQ:RSLS
Holding RSLS?
Track your performance easily

ReShape Lifesciences (RSLS) Cash flow

464 Followers

ReShape Lifesciences Cash Flow

RSLS's free cash flow for Q2 2024 was $-1.36M. For the 2024 fiscal year, RSLS's free cash flow was decreased by $5.02M and operating cash flow was $-1.36M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -8.67M$ -16.96M$ -21.90M$ -15.38M$ -8.55M$ -14.20M
Investing Cash Flow
-$ -10.00K$ -92.00K$ 1.85M$ -2.39M$ -2.01M
Financing Cash Flow
$ 5.15M$ 17.57M$ 3.13M$ 33.30M$ 11.07M$ 13.66M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 11.87M$ 4.60M$ 3.96M$ 22.82M$ 3.01M$ 2.98M
Income Tax Paid Supplemental Data
$ 22.00K$ 10.00K$ 5.00K$ 102.00K$ 40.00K-
Interest Paid Supplemental Data
---$ 296.00K-$ 719.00K
Issuance Of Capital Stock
$ 11.19M$ 13.44M$ 639.00K--$ 23.38M
Issuance Of Debt
---$ -9.50M$ 10.46M$ -10.20M
Repayment Of Debt
---$ -10.50M-$ -22.20M
Free Cash Flow
$ -8.67M$ -16.97M$ -21.99M$ -15.73M$ -8.94M$ -14.41M
Domestic Sales
------
Foreign Sales
------
Currency in USD

ReShape Lifesciences Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis